FDA approves first targetted therapy to treat aggressive form of lung cancer
The FDA also approved the FoundationOne CDx assay (F1CDx) as a companion diagnostic for Tabrecta
The US Food and Drug…
Recover your password.
A password will be e-mailed to you.